|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Feng RM, Zong YN, Cao SM and Xu RH:
Current cancer situation in China: Good or bad news from the 2018
global cancer statistics? Cancer Commun (Lond). 39:222019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Worni M, Martin J, Gloor B, Pietrobon R,
D'Amico TA, Akushevich I and Berry MF: Does surgery improve
outcomes for esophageal squamous cell carcinoma? An analysis using
the surveillance epidemiology and end results registry from 1998 to
2008. J Am Coll Surg. 215:643–651. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen Y, Ye J, Zhu Z, Zhao W, Zhou J, Wu C,
Tang H, Fan M, Li L, Lin Q, et al: Comparing paclitaxel plus
fluorouracil versus cisplatin plus fluorouracil in
chemoradiotherapy for locally advanced esophageal squamous cell
cancer: A randomized, multicenter, phase III clinical trial. J Clin
Oncol. 37:1695–1703. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rawat S, Kumar G, Kakria A, Sharma MK and
Chauhan D: Chemoradiotherapy in the management of locally advanced
squamous cell carcinoma esophagus: Is surgical resection required?
J Gastrointest Cancer. 44:277–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bedenne L, Michel P, Bouche O, Milan C,
Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, et al:
Chemoradiation followed by surgery compared with chemoradiation
alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol.
25:1160–1168. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Conroy T, Galais MP, Raoul JL, Bouché O,
Gourgou-Bourgade S, Douillard JY, Etienne PL, Boige V, Martel-Lafay
I, Michel P, et al: Definitive chemoradiotherapy with FOLFOX versus
fluorouracil and cisplatin in patients with oesophageal cancer
(PRODIGE5/ACCORD17): Final results of a randomised, phase 2/3
trial. Lancet Oncol. 15:305–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen MF, Yang YH, Lai CH, Chen PC and Chen
WC: Outcome of patients with esophageal cancer: A nationwide
analysis. Ann Surg Oncol. 20:3023–3030. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen MF, Chen PT, Lu MS, Lee CP and Chen
WC: Survival benefit of surgery to patients with esophageal
squamous cell carcinoma. Sci Rep. 7:461392017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stahl M, Lehmann N, Walz MK, Stuschke M
and Wilke H: Prediction of prognosis after trimodal therapy in
patients with locally advanced squamous cell carcinoma of the
oesophagus. Eur J Cancer. 48:2977–2982. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bettegowda C, Sausen M, Leary RJ, Kinde I,
Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al:
Detection of circulating tumor DNA in early- and late-stage human
malignancies. Sci Transl Med. 6:224ra242014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Murtaza M, Dawson SJ, Pogrebniak K, Rueda
OM, Provenzano E, Grant J, Chin SF, Tsui DWY, Marass F, Gale D, et
al: Multifocal clonal evolution characterized using circulating
tumour DNA in a case of metastatic breast cancer. Nat Commun.
6:87602015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Olsson E, Winter C, George A, Chen Y,
Howlin J, Tang MH, Dahlgren M, Schulz R, Grabau D, van Westen D, et
al: Serial monitoring of circulating tumor DNA in patients with
primary breast cancer for detection of occult metastatic disease.
EMBO Mol Med. 7:1034–1047. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abbosh C, Birkbak NJ, Wilson GA,
Jamal-Hanjani M, Constantin T, Salari R, Le Quesne J, Moore DA,
Veeriah S, Rosenthal R, et al: Phylogenetic ctDNA analysis depicts
early-stage lung cancer evolution. Nature. 545:446–451. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Reinert T, Scholer LV, Thomsen R, Tobiasen
H, Vang S, Nordentoft I, Lamy P, Kannerup AS, Mortensen FV,
Stribolt K, et al: Analysis of circulating tumour DNA to monitor
disease burden following colorectal cancer surgery. Gut.
65:625–634. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pectasides E, Stachler MD, Derks S, Liu Y,
Maron S, Islam M, Alpert L, Kwak H, Kindler H, Polite B, et al:
Genomic heterogeneity as a barrier to precision medicine in
gastroesophageal adenocarcinoma. Cancer Discov. 8:37–48. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Newman AM, Bratman SV, To J, Wynne JF,
Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, et
al: An ultrasensitive method for quantitating circulating tumor DNA
with broad patient coverage. Nat Med. 20:548–554. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tie J, Wang Y, Tomasetti C, Li L, Springer
S, Kinde I, Silliman N, Tacey M, Wong HL, Christie M, et al:
Circulating tumor DNA analysis detects minimal residual disease and
predicts recurrence in patients with stage II colon cancer. Sci
Transl Med. 8:346ra922016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Garcia-Murillas I, Schiavon G, Weigelt B,
Ng C, Hrebien S, Cutts RJ, Cheang M, Osin P, Nerurkar A, Kozarewa
I, et al: Mutation tracking in circulating tumor DNA predicts
relapse in early breast cancer. Sci Transl Med. 7:302ra1332015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luo H, Li H, Hu Z, Wu H, Liu C, Li Y,
Zhang X, Lin P, Hou Q, Ding G, et al: Noninvasive diagnosis and
monitoring of mutations by deep sequencing of circulating tumor DNA
in esophageal squamous cell carcinoma. Biochem Biophys Res Commun.
471:596–602. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. (7th edition).
Springer; New York, NY: pp. 103–115. 2010
|
|
23
|
Yang X, Chu Y, Zhang R, Han Y, Zhang L, Fu
Y, Li D, Peng R, Li D, Ding J, et al: Technical validation of a
next-generation sequencing assay for detecting clinically relevant
levels of breast cancer-related single-nucleotide variants and copy
number variants using simulated Cell-Free DNA. J Mol Diagn.
19:525–536. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Forbes SA, Beare D, Boutselakis H, Bamford
S, Bindal N, Tate J, Cole CG, Ward S, Dawson E, Ponting L, et al:
COSMIC: Somatic cancer genetics at high-resolution. Nucleic Acids
Res. 45:D777–D783. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song Y, Li L, Ou Y, Gao Z, Li E, Li X,
Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic
alterations in oesophageal squamous cell cancer. Nature. 509:91–95.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, Sun
ZM, Zhang F, Zhao ZR, Li ZT, Liu ZY, et al: Genetic landscape of
esophageal squamous cell carcinoma. Nat Genet. 46:1097–1102. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qin HD, Liao XY, Chen YB, Huang SY, Xue
WQ, Li FF, Ge XS, Liu DQ, Cai Q, Long J, et al: Genomic
characterization of esophageal squamous cell carcinoma reveals
critical genes underlying tumorigenesis and poor prognosis. Am J
Hum Genet. 98:709–727. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cancer Genome Atlas Research Network, ;
Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA,
Ellrott K, Shmulevich I, Sander C and Stuart JM: The Cancer Genome
Atlas Pan-Cancer analysis project. Nat Genet. 45:1113–1120. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li H and Durbin R: Fast and accurate short
read alignment with Burrows-Wheeler transform. Bioinformatics.
25:1754–1760. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cibulskis K, Lawrence MS, Carter SL,
Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES
and Getz G: Sensitive detection of somatic point mutations in
impure and heterogeneous cancer samples. Nat Biotechnol.
31:213–219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McKenna A, Hanna M, Banks E, Sivachenko A,
Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly
M and DePristo MA: The genome analysis toolkit: A MapReduce
framework for analyzing next-generation DNA sequencing data. Genome
Res. 20:1297–1303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Robinson JT, Thorvaldsdottir H, Winckler
W, Guttman M, Lander ES, Getz G and Mesirov JP: Integrative
genomics viewer. Nat Biotechnol. 29:24–26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang K, Li M and Hakonarson H: ANNOVAR:
Functional annotation of genetic variants from high-throughput
sequencing data. Nucleic Acids Res. 38:e1642010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Oh D and Kim JH: The current evidence on
neoadjuvant therapy for locally advanced esophageal squamous cell
carcinoma. Korean J Thorac Cardiovasc Surg. 53:160–167. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu PC and Posner MC: The role of surgery
in the management of oesophageal cancer. Lancet Oncol. 4:481–488.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stahl M, Stuschke M, Lehmann N, Meyer HJ,
Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, et
al: Chemoradiation with and without surgery in patients with
locally advanced squamous cell carcinoma of the esophagus. J Clin
Oncol. 23:2310–2317. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsao SC, Weiss J, Hudson C, Christophi C,
Cebon J, Behren A and Dobrovic A: Monitoring response to therapy in
melanoma by quantifying circulating tumour DNA with droplet digital
PCR for BRAF and NRAS mutations. Sci Rep. 5:111982015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dawson SJ, Tsui DW, Murtaza M, Biggs H,
Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B,
et al: Analysis of circulating tumor DNA to monitor metastatic
breast cancer. N Engl J Med. 368:1199–1209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Diehl F, Schmidt K, Choti MA, Romans K,
Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, et al:
Circulating mutant DNA to assess tumor dynamics. Nat Med.
14:985–990. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Y, Zhao C, Chang L, Jia R, Liu R,
Zhang Y, Gao X, Li J, Chen R, Xia X, et al: Circulating tumor DNA
analyses predict progressive disease and indicate
trastuzumab-resistant mechanism in advanced gastric cancer.
EBioMedicine. 43:261–269. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Antonia SJ, Villegas A, Daniel D, Vicente
D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, et
al: Overall survival with durvalumab after chemoradiotherapy in
stage III NSCLC. N Engl J Med. 379:2342–2350. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Antonia SJ, Villegas A, Daniel D, Vicente
D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, et
al: Durvalumab after chemoradiotherapy in stage III non-small-cell
lung cancer. N Engl J Med. 377:1919–1929. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kelly RJ, Lockhart AC, Jonker DJ, Melichar
B, Andre T, Chau I, Clarke SJ, Cleary JM, Doki Y, Franke FA, et al:
CheckMate 577: A randomized, double-blind, phase 3 study of
nivolumab (Nivo) or placebo in patients (Pts) with resected lower
esophageal (E) or gastroesophageal junction (GEJ) cancer. J Clin
Oncol. 35 (4 Suppl):TPS2122017. View Article : Google Scholar
|
|
44
|
Yang L, Zhang X, MacKay M, Foox J, Hou Q,
Zheng X, Zhou R, Huang M, Jing Z, Mason CE and Wu S: Identification
of radioresponsive genes in esophageal cancer from longitudinal and
single cell exome sequencing. Int J Radiat Oncol Biol Phys.
108:1103–1114. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
He Q, Li J, Dong F, Cai C and Zou X: LKB1
promotes radioresistance in esophageal cancer cells exposed to
radiation, by suppression of apoptosis and activation of autophagy
via the AMPK pathway. Mol Med Rep. 16:2205–2210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Phallen J, Sausen M, Adleff V, Leal A,
Hruban C, White J, Anagnostou V, Fiksel J, Cristiano S, Papp E, et
al: Direct detection of early-stage cancers using circulating tumor
DNA. Sci Transl Med. 9:eaan24152017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Newman AM, Lovejoy AF, Klass DM, Kurtz DM,
Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, et al:
Integrated digital error suppression for improved detection of
circulating tumor DNA. Nat Biotechnol. 34:547–555. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lin DC, Hao JJ, Nagata Y, Xu L, Shang L,
Meng X, Sato Y, Okuno Y, Varela AM, Ding LW, et al: Genomic and
molecular characterization of esophageal squamous cell carcinoma.
Nat Genet. 46:467–473. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hao JJ, Lin DC, Dinh HQ, Mayakonda A,
Jiang YY, Chang C, Jiang Y, Lu CC, Shi ZZ, Xu X, et al: Spatial
intratumoral heterogeneity and temporal clonal evolution in
esophageal squamous cell carcinoma. Nat Genet. 48:1500–1507. 2016.
View Article : Google Scholar : PubMed/NCBI
|
